COST-EFFECTIVENESS ANALYSIS OF DIFELIKEFALIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE ASSOCIATED-PRURITUS IN SPAIN

被引：0
|
作者：
Sanchez-Alvarez, Emilio E.
Poveda, J. L. [1 ]
Sanchez-Villanueva, R. [2 ]
Ramirez, de Arellano Serna A. [3 ]
Olga, R. [3 ]
De, La Paz Canizares I. [4 ]
Hernaez Colque, M. [5 ]
机构：
[1] Hosp Univ & Politecn La Fe, Valencia, Spain
[2] La Paz Hosp, Madrid, Spain
[3] CSL Vifor, Glattbrugg, ZH, Switzerland
[4] Alira Hlth, Barcelona, Spain
[5] Alira Hlth, Madrid, Spain
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE364
引用
收藏
页码：S126 / S126
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF DIFELIKEFALIN COMPARED TO BEST SUPPORTIVE CARE FOR TREATMENT OF CHRONIC KIDNEY DISEASE-ASSOCIATED PRURITUS IN AUSTRALIA
    Jackson, D.
    Ratkovic, M.
    Tilden, D.
    Soro, M.
    Schaufler, T.
    Grava, A.
    Harsley, S.
    Brydon, S.
    VALUE IN HEALTH, 2024, 27 (12) : S179 - S179
  • [2] COST-EFFECTIVENESS ANALYSIS OF DIFELIKEFALIN FOR PATIENTS WITH CHRONIC KIDNEY DISEASE-ASSOCIATED PRURITUS (CKD AP) UNDERGOING HAEMODIALYSIS IN ITALY
    Cicchetti, A.
    Manenti, L.
    Mennini, F. S.
    Aiello, A.
    Mariano, E.
    Prada, M.
    Soro, M.
    VALUE IN HEALTH, 2023, 26 (12) : S163 - S163
  • [3] Cost effectiveness of difelikefalin for the treatment of patients with chronic kidney disease-associated pruritus undergoing hemodialysis in Italy
    Manenti, Lucio
    Marcellusi, Andrea
    Di Brino, Eugenio
    Aiello, Andrea
    Barugolo, Asia
    Berto, Patrizia
    Soro, Marco
    JOURNAL OF NEPHROLOGY, 2025, 38 (01) : 251 - 259
  • [4] Difelikefalin for pruritus associated with chronic kidney disease
    不详
    AUSTRALIAN PRESCRIBER, 2024, 47 (04) : 132 - 133
  • [5] Cost-Effectiveness of Difelikefalin compared to Standard Care for treating Chronic Kidney Disease Associated Pruritus (CKD-aP)
    Thokala, Praveen
    Si, Pann Ei Hnynn
    Hernandez, Monica
    Sasso, Alessandro
    Schaufler, Thilo
    Soro, Marco
    Fotheringham, James
    MEDICAL DECISION MAKING, 2024, 44 (02) : NP160 - NP160
  • [6] Difelikefalin (Korsuva) for Chronic Kidney Disease-Associated Pruritus
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2022, 64 (1643): : 18 - 19
  • [7] Difelikefalin in the Treatment of Chronic Kidney Disease-Associated Pruritus: A Systematic Review
    Wala, Kamila
    Szepietowski, Jacek C.
    PHARMACEUTICALS, 2022, 15 (08)
  • [8] COST-EFFECTIVENESS OF DIFELIKEFALIN FOR THE TREATMENT OF MODERATE TO SEVERE CHRONIC KIDNEY DISEASE-ASSOCIATED PRURITUS (CKD-AP) IN ADULT PATIENTS RECEIVING IN-CENTRE HAEMODIALYSIS
    Collins, C.
    Edmonds, T.
    Taylor, I
    Mumford, A.
    Darlington, O.
    Schaufler, T.
    Soro, M.
    Baxter, G.
    VALUE IN HEALTH, 2023, 26 (12) : S74 - S74
  • [9] Difelikefalin for the treatment of moderate-to-severe pruritus associated with chronic kidney disease on hemodialysis
    Rastogi, Anjay
    Fishbane, Steven
    Lerma, Edgar
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023, 16 (05) : 387 - 400
  • [10] Correction: Difelikefalin in pruritus associated with chronic kidney disease: a profile of its use
    Yvette N. Lamb
    Drugs & Therapy Perspectives, 2022, 38 : 500 - 500
12345